X
20
Cadila Healthcare Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is BUPROPION HYDROCHLORIDE, with a corresponding US DMF Number 19297.
Remarkably, this DMF maintains an Inactive status since its submission on March 28, 2006, highlighting commitment to regulatory compliance.